Yale Cancer Center

11 results

Rate Search Results

News
YSM Faculty Win Awards From the Blavatnik Fund for Innovation at Yale
This year’s awardees are tackling some of the most urgent life science challenges with projects spanning novel therapeutics to AI-powered medical solutions.
Source: Yale Ventures
28 Feb 2025
News
Yale research advances presented at American Society of Hematology annual meeting
Physicians, scientists, and trainees fromYale Cancer Center and Smilow Cancer Hospital attended the 66th annual meeting of the American Society of Hematology in San Diego, CA, December 7-10, 2024 to present the latest advances in hematological research and clinical care from Yale.
18 Dec 2024
News
Multidisciplinary CMCO Making Strides
The term “basic” is used to describe scientific discoveries made on a fundamental level. They are essential to translational work by scientists and physician-scientists, who bridge cancer biology with clinical investigation, specifically to bring better treatments and diagnostic tools to patients. It’s been an exciting year for basic science research at the Center for Molecular and Cellular Oncology (CMCO), says its inaugural director Markus Müschen, MD, PhD, Arthur H. and Isabel Bunker Professor of Hematology at Yale School of Medicine.
15 Apr 2024
News
Dr. Markus Müschen Elected to CASE
Markus Müschen, MD, PhD, Arthur H. and Isabel Bunker Professor of Medicine (Hematology) and Professor of Immunobiology, has been elected to Connecticut Academy of Science and Engineering (CASE) for 2023.
2 Mar 2023
News
Connecticut Academy of Science and Engineering Elects 35 New Members in 2023
East Hartford, CT —The Connecticut Academy of Science and Engineering (CASE) announces the election of 35 of Connecticut’s leading experts in science, technology, engineering, mathematics, and medicine to membership in the Academy. The new members will be introduced at the Academy’s 48th Annual Meeting and Dinner to be held at the Woodwinds in Branford on May 24, 2023.
Source: Connecticut Academy of Science and Engineering
23 Feb 2023
News
Discoveries & Impact (May 2022)
Discoveries & Impact (May 2022)
12 May 2022
News
Yale’s Markus Müschen Receives Prestigious NCI Outstanding Investigator Award
The National Cancer Institute has recognized Markus Müschen, MD, PhD, with its Outstanding Investigator Award.
6 Oct 2021
News
Yale Cancer Center Researchers Discover Common Mechanism Causing Autoimmune Disease and Blood Cancers
In a study by Yale Cancer Center, researchers report on the discovery of a common mechanism that promotes both autoimmune diseases and blood cancers, including the blood diseases Acute Lymphoblastic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL).
19 Apr 2021
News
Yale Cancer Center Researchers Discover Mechanism to Overcome Drug Resistance in B-Cell Acute Lymphoblastic Leukemia
In a new study led by Yale Cancer Center, researchers have discovered a novel metabolic gatekeeper mechanism for leukemia. This mechanism depends on a molecule called PON2, which could lead to a new treatment for the disease.
31 Jan 2021
News
Yale Cancer Center Researchers Uncover New Mechanism of Immune-Cell Activation
In a new study by Yale Cancer Center, scientists have identified the short endosomal protein interferon-inducible transmembrane protein 3 or IFITM3 as a central amplifier to supercharge activation of immune cells.
3 Nov 2020
News
Müschen Named to Arthur H. and Isabel Bunker Professorship at Yale
Dr. Markus Müschen, who joined the Yale School of Medicine faculty this fall as the Arthur H. and Isabel Bunker Professor of Medicine and professor of immunobiology, studies oncogenic signaling and clonal evolution in B cell malignancies, including acute lymphoblastic leukemia, the most frequent type of cancer in children and young adults.
Source: YaleNews
21 Oct 2020